Cargando…

Lipidomic signatures align with inflammatory patterns and outcomes in critical illness

Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Junru, Cyr, Anthony, Gruen, Danielle S., Lovelace, Tyler C., Benos, Panayiotis V., Das, Jishnu, Kar, Upendra K., Chen, Tianmeng, Guyette, Francis X., Yazer, Mark H., Daley, Brian J., Miller, Richard S., Harbrecht, Brian G., Claridge, Jeffrey A., Phelan, Herb A., Zuckerbraun, Brian S., Neal, Matthew D., Johansson, Pär I., Stensballe, Jakob, Namas, Rami A., Vodovotz, Yoram, Sperry, Jason L., Billiar, Timothy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647252/
https://www.ncbi.nlm.nih.gov/pubmed/36357394
http://dx.doi.org/10.1038/s41467-022-34420-4
_version_ 1784827347472482304
author Wu, Junru
Cyr, Anthony
Gruen, Danielle S.
Lovelace, Tyler C.
Benos, Panayiotis V.
Das, Jishnu
Kar, Upendra K.
Chen, Tianmeng
Guyette, Francis X.
Yazer, Mark H.
Daley, Brian J.
Miller, Richard S.
Harbrecht, Brian G.
Claridge, Jeffrey A.
Phelan, Herb A.
Zuckerbraun, Brian S.
Neal, Matthew D.
Johansson, Pär I.
Stensballe, Jakob
Namas, Rami A.
Vodovotz, Yoram
Sperry, Jason L.
Billiar, Timothy R.
author_facet Wu, Junru
Cyr, Anthony
Gruen, Danielle S.
Lovelace, Tyler C.
Benos, Panayiotis V.
Das, Jishnu
Kar, Upendra K.
Chen, Tianmeng
Guyette, Francis X.
Yazer, Mark H.
Daley, Brian J.
Miller, Richard S.
Harbrecht, Brian G.
Claridge, Jeffrey A.
Phelan, Herb A.
Zuckerbraun, Brian S.
Neal, Matthew D.
Johansson, Pär I.
Stensballe, Jakob
Namas, Rami A.
Vodovotz, Yoram
Sperry, Jason L.
Billiar, Timothy R.
author_sort Wu, Junru
collection PubMed
description Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in critically ill humans. The major findings include an early loss of all classes of circulating lipids followed by a delayed and selective lipogenesis in patients destined to remain critically ill. The previously reported survival benefit of early thawed plasma administration was associated with preserved lipid levels that related to favorable changes in coagulation and inflammation biomarkers in causal modelling. Phosphatidylethanolamines (PE) were elevated in patients with persistent critical illness and PE levels were prognostic for worse outcomes not only in trauma but also severe COVID-19 patients. Here we show selective rise in systemic PE as a common prognostic feature of critical illness.
format Online
Article
Text
id pubmed-9647252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96472522022-11-14 Lipidomic signatures align with inflammatory patterns and outcomes in critical illness Wu, Junru Cyr, Anthony Gruen, Danielle S. Lovelace, Tyler C. Benos, Panayiotis V. Das, Jishnu Kar, Upendra K. Chen, Tianmeng Guyette, Francis X. Yazer, Mark H. Daley, Brian J. Miller, Richard S. Harbrecht, Brian G. Claridge, Jeffrey A. Phelan, Herb A. Zuckerbraun, Brian S. Neal, Matthew D. Johansson, Pär I. Stensballe, Jakob Namas, Rami A. Vodovotz, Yoram Sperry, Jason L. Billiar, Timothy R. Nat Commun Article Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in critically ill humans. The major findings include an early loss of all classes of circulating lipids followed by a delayed and selective lipogenesis in patients destined to remain critically ill. The previously reported survival benefit of early thawed plasma administration was associated with preserved lipid levels that related to favorable changes in coagulation and inflammation biomarkers in causal modelling. Phosphatidylethanolamines (PE) were elevated in patients with persistent critical illness and PE levels were prognostic for worse outcomes not only in trauma but also severe COVID-19 patients. Here we show selective rise in systemic PE as a common prognostic feature of critical illness. Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9647252/ /pubmed/36357394 http://dx.doi.org/10.1038/s41467-022-34420-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wu, Junru
Cyr, Anthony
Gruen, Danielle S.
Lovelace, Tyler C.
Benos, Panayiotis V.
Das, Jishnu
Kar, Upendra K.
Chen, Tianmeng
Guyette, Francis X.
Yazer, Mark H.
Daley, Brian J.
Miller, Richard S.
Harbrecht, Brian G.
Claridge, Jeffrey A.
Phelan, Herb A.
Zuckerbraun, Brian S.
Neal, Matthew D.
Johansson, Pär I.
Stensballe, Jakob
Namas, Rami A.
Vodovotz, Yoram
Sperry, Jason L.
Billiar, Timothy R.
Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
title Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
title_full Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
title_fullStr Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
title_full_unstemmed Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
title_short Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
title_sort lipidomic signatures align with inflammatory patterns and outcomes in critical illness
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647252/
https://www.ncbi.nlm.nih.gov/pubmed/36357394
http://dx.doi.org/10.1038/s41467-022-34420-4
work_keys_str_mv AT wujunru lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT cyranthony lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT gruendanielles lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT lovelacetylerc lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT benospanayiotisv lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT dasjishnu lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT karupendrak lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT chentianmeng lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT guyettefrancisx lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT yazermarkh lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT daleybrianj lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT millerrichards lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT harbrechtbriang lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT claridgejeffreya lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT phelanherba lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT zuckerbraunbrians lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT nealmatthewd lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT johanssonpari lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT stensballejakob lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT namasramia lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT vodovotzyoram lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT sperryjasonl lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT billiartimothyr lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness
AT lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness